Literature DB >> 33604190

The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer.

Mengya Wang1,2, Jingjing Jing1,2, Hao Li3, Jingwei Liu2, Yuan Yuan1,2, Liping Sun1,2.   

Abstract

BACKGROUND: Autophagy is an evolutionally highly conserved process, accompanied by the dynamic changes of various molecules, which is necessary for the orderly degradation and recycling of cellular components. The aim of the study was to identify the role of autophagy-related (ATG) genes in the occurrence and development of gastric cancer (GC).
METHODS: Data from Oncomine dataset was used for the differential expression analysis between cancer and normal tissues. The association of ATG genes expression with clinicopathologic indicators was evaluated by The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) database. Moreover, using the TCGA datasets, the prognostic role of ATG genes was assessed. A nomogram was further built to assess the independent prognostic factors.
RESULTS: The expression of autophagy-related genes AMBRA1, ATG4B, ATG7, ATG10, ATG12, ATG16L2, GABARAPL2, GABARAPL1, ULK4 and WIPI2 showed differences between cancer and normal tissues. After verification, ATG14 and ATG4D were significantly associated with TNM stage. ATG9A, ATG2A, and ATG4D were associated with T stage. VMP1 and ATG4A were low-expressed in patients without lymph node metastasis. No gene in autophagy pathway was associated with M stage. Further multivariate analysis suggested that ATG4D and MAP1LC3C were independent prognostic factors for GC. The C-index of nomogram was 0.676 and the 95% CI was 0.628 to 0.724.
CONCLUSION: Our study provided a comprehensive illustration of ATG genes expression characteristics in GC. Abnormal expressions of the ubiquitin-like conjugated system in ATG genes plays a key role in the occurrence of GC. ATG8/LC3 sub-system may play an important role in development and clinical outcome of GC. In the future, it is necessary to further elucidate the alterations of specific ATG8/LC3 forms in order to provide insights for the discovery, diagnosis, or targeting for GC. ©2021 Wang et al.

Entities:  

Keywords:  Gastric cancer; Gene expression; TCGA; ATG4; Autophagy

Year:  2021        PMID: 33604190      PMCID: PMC7866901          DOI: 10.7717/peerj.10814

Source DB:  PubMed          Journal:  PeerJ        ISSN: 2167-8359            Impact factor:   2.984


  36 in total

1.  ATG4B promotes colorectal cancer growth independent of autophagic flux.

Authors:  Pei-Feng Liu; Chung-Man Leung; Yu-Hsiang Chang; Jin-Shiung Cheng; Jih-Jung Chen; Chung-Jeu Weng; Kuo-Wang Tsai; Chien-Jen Hsu; Yen-Chen Liu; Ping-Chi Hsu; Hung-Wei Pan; Chih-Wen Shu
Journal:  Autophagy       Date:  2014-06-12       Impact factor: 16.016

2.  Autophagy is a major mechanism for the dual effects of curcumin on renal cell carcinoma cells.

Authors:  Qian Deng; Liang Liang; Quanhai Liu; Wanli Duan; Yazhuo Jiang; Liandong Zhang
Journal:  Eur J Pharmacol       Date:  2018-03-01       Impact factor: 4.432

3.  Transgenic expression of GFP-LC3 perturbs autophagy in exocrine pancreas and acute pancreatitis responses in mice.

Authors:  Olga A Mareninova; Wenzhuo Jia; Sophie R Gretler; Conner L Holthaus; Diana D H Thomas; Michael Pimienta; Dustin L Dillon; Anna S Gukovskaya; Ilya Gukovsky; Guy E Groblewski
Journal:  Autophagy       Date:  2020-01-16       Impact factor: 16.016

4.  The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation.

Authors:  C Loncle; M I Molejon; S Lac; J I Tellechea; G Lomberk; L Gramatica; M F Fernandez Zapico; N Dusetti; R Urrutia; J L Iovanna
Journal:  Cell Death Dis       Date:  2016-07-14       Impact factor: 8.469

5.  Ambra1 modulates the sensitivity of breast cancer cells to epirubicin by regulating autophagy via ATG12.

Authors:  Wei-Liang Sun; Li Wang; Jie Luo; Hua-Wei Zhu; Zheng-Wen Cai
Journal:  Cancer Sci       Date:  2018-08-24       Impact factor: 6.716

6.  The 2019 WHO classification of tumours of the digestive system.

Authors:  Iris D Nagtegaal; Robert D Odze; David Klimstra; Valerie Paradis; Massimo Rugge; Peter Schirmacher; Kay M Washington; Fatima Carneiro; Ian A Cree
Journal:  Histopathology       Date:  2019-11-13       Impact factor: 5.087

7.  The reactome pathway knowledgebase.

Authors:  Bijay Jassal; Lisa Matthews; Guilherme Viteri; Chuqiao Gong; Pascual Lorente; Antonio Fabregat; Konstantinos Sidiropoulos; Justin Cook; Marc Gillespie; Robin Haw; Fred Loney; Bruce May; Marija Milacic; Karen Rothfels; Cristoffer Sevilla; Veronica Shamovsky; Solomon Shorser; Thawfeek Varusai; Joel Weiser; Guanming Wu; Lincoln Stein; Henning Hermjakob; Peter D'Eustachio
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

8.  Autophagy gene expression profiling identifies a defective microtubule-associated protein light chain 3A mutant in cancer.

Authors:  Joana R Costa; Krisna Prak; Sarah Aldous; Christina Anja Gewinner; Robin Ketteler
Journal:  Oncotarget       Date:  2016-07-05

9.  The Influence of Tumor Microenvironment on ATG4D Gene Expression in Colorectal Cancer Patients.

Authors:  Justyna Gil; David Ramsey; Pawel Pawlowski; Elzbieta Szmida; Przemyslaw Leszczynski; Marek Bebenek; Maria M Sasiadek
Journal:  Med Oncol       Date:  2018-10-29       Impact factor: 3.064

10.  Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition.

Authors:  Junfeng Wu; Wei Li; Jinzhuo Ning; Weimin Yu; Ting Rao; Fan Cheng
Journal:  Onco Targets Ther       Date:  2019-01-09       Impact factor: 4.147

View more
  2 in total

1.  Salmonella Enteritidis GalE Protein Inhibits LPS-Induced NLRP3 Inflammasome Activation.

Authors:  Tingting Huang; Dan Gu; Yaxin Guo; Ang Li; Xilong Kang; Xinan Jiao; Zhiming Pan
Journal:  Microorganisms       Date:  2022-04-26

Review 2.  ATP and cancer immunosurveillance.

Authors:  Oliver Kepp; Lucillia Bezu; Takahiro Yamazaki; Francesco Di Virgilio; Mark J Smyth; Guido Kroemer; Lorenzo Galluzzi
Journal:  EMBO J       Date:  2021-06-14       Impact factor: 14.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.